Investors Alert: Deadline Reminder for Securities Fraud Case
Investors in Applied Therapeutics, Inc. are being reminded by the law firm Kessler Topaz Meltzer & Check, LLP about an upcoming deadline in a securities fraud class action lawsuit. The lawsuit accuses Applied Therapeutics of making misleading statements about the results of a drug trial, causing its stock price to fall. Investors who purchased shares between November 9, 2020, and January 4, 2021, are encouraged to participate in the lawsuit before the deadline.
The allegations against Applied Therapeutics stem from the company’s announcement of results from its Genomics-Driven Trial (GALT) in treating diabetic cardiomyopathy. The lawsuit claims that the company failed to disclose important information about the trial, leading to a drop in its stock price when the truth was revealed.
Investors who suffered losses as a result of purchasing Applied Therapeutics stock during the specified time period may be eligible to participate in the class action lawsuit. By joining the lawsuit, investors can seek to recover their losses and hold the company accountable for any alleged wrongdoing.
It is important for investors to be aware of their rights and options in situations like this. If you believe you may have been affected by the alleged securities fraud at Applied Therapeutics, consider seeking legal counsel to learn more about how you can participate in the lawsuit before the deadline.
Remember, deadlines in class action lawsuits are strict, so it is crucial to take action promptly if you wish to be included in any potential settlement. Stay informed and protect your investments by staying up to date on developments in this case.
